_id
69171df63c536f8df2316740
Ticker
THAR
Name
Tharimmune Inc.
Exchange
NASDAQ
Address
34 Shrewsbury Avenue, Red Bank, NJ, United States, 07701
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://www.tharimmune.com
Description
Tharimmune, Inc., a clinical-stage biotechnology company, engages in the development of therapeutic candidates for immunology and inflammation conditions in the United States. It is involved in the development of TH104 for the proposed indication of temporary prophylaxis of respiratory and/or nervous system depression in military personnel and chemical incident responders entering and area contaminated with opioids, as well as is in phase 2 study in patients with chronic pruritus in primary biliary cholangitis. The company also engages in the development of TH023 to treat autoimmune indications; and HS1940, a bispecific biologic against PD-1 and vascular endothelial growth receptor antibody that targets both receptors. It has a research collaboration and product license agreement with Minotaur Therapeutics, Inc. for the development of proprietary targeted biologics. The company was formerly known as Hillstream BioPharma, Inc. and changed its name to Tharimmune, Inc. in September 2023. Tharimmune, Inc. was incorporated in 2017 and is based in Red Bank, New Jersey.
Last Close
3.19
Volume
552709
Current Price
2.92
Change
-0.1
Last Updated
2026-01-07T13:04:04.508Z
Image
data:image/webp;base64,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
Ipo Date
2022-01-12T00:00:00.000Z
Market Cap
108288464
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Rating
5
Target Price
5
Strong Buy
1
Buy
0
Hold
0
Sell
0
Strong Sell
0
Current Quarter
2025-09-30
Revenue
0
Cost Of Revenue
-
Gross Profit
-
Operating Expenses
2093578
Operating Income
-2093578
Interest Expense
9648
Pretax Income
-2101838
Net Income
-2101838
Eps
-0.336729997185156
Dividends Per Share
-
Shares Outstanding
35044812
Income Tax Expense
-
EBITDA
-2092190
Operating Margin
-
Total Other Income Expense Net
-8260
Cash
7610340
Short Term Investments
-
Receivables
-
Inventories
-
Total Current Assets
7699378
Property Plant Equipment
-
Total Assets
7699378
Payables
659254
Short Term Debt
-
Long Term Debt
-
Total Liabilities
1544551
Equity
6154827
Bs_currency_symbol
USD
Depreciation
24832
Change In Working Capital
-372513
Cash From Operations
-1855169
Capital Expenditures
1
Cash From Investing
-
Cash From Financing
7223529
Net Change In Cash
5368360
Cf_currency_symbol
USD
PE
-
PB
2.9613138240928625
ROE
-34.149424508601136
ROA
-27.298802578597908
FCF
-1855170
Fcf Percent
-
Piotroski FScore
1
Health Score
43
Deep Value Investing Score
3
Defensive Investing Score
7
Dividend Investing Score
1.5
Economic Moat Investing Score
3.8
Garp Investing Score
2
Growth Investing Score
0.5
Momentum Investing Score
2
Net Net Investing Score
2.5
Quality Investing Score
2.5
Value Investing Score
5
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
0
Quarters > 0 > income Statement > cost Of Revenue
-
Quarters > 0 > income Statement > gross Profit
-
Quarters > 0 > income Statement > operating Expenses
2093578
Quarters > 0 > income Statement > operating Income
-2093578
Quarters > 0 > income Statement > interest Expense
9648
Quarters > 0 > income Statement > pretax Income
-2101838
Quarters > 0 > income Statement > net Income
-2101838
Quarters > 0 > income Statement > eps
-0.336729997185156
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
6241909
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-2092190
Quarters > 0 > income Statement > operating Margin
-
Quarters > 0 > income Statement > total Other Income Expense Net
-8260
Quarters > 0 > income Statement > currency_symbol
USD
Quarters > 0 > balance Sheet > cash
7610340
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
-
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
7699378
Quarters > 0 > balance Sheet > property Plant Equipment
-
Quarters > 0 > balance Sheet > total Assets
7699378
Quarters > 0 > balance Sheet > payables
659254
Quarters > 0 > balance Sheet > short Term Debt
-
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
1544551
Quarters > 0 > balance Sheet > equity
6154827
Quarters > 0 > balance Sheet > currency_symbol
USD
Quarters > 0 > cash Flow > net Income
-2101838
Quarters > 0 > cash Flow > depreciation
24832
Quarters > 0 > cash Flow > change In Working Capital
-372513
Quarters > 0 > cash Flow > cash From Operations
-1855169
Quarters > 0 > cash Flow > capital Expenditures
1
Quarters > 0 > cash Flow > cash From Investing
-
Quarters > 0 > cash Flow > cash From Financing
7223529
Quarters > 0 > cash Flow > net Change In Cash
5368360
Quarters > 0 > cash Flow > currency_symbol
USD
Quarters > 0 > ratios > PE
-0.336729997185156
Quarters > 0 > ratios > PB
2.9613138240928625
Quarters > 0 > ratios > ROE
-34.149424508601136
Quarters > 0 > ratios > ROA
-27.298802578597908
Quarters > 0 > ratios > FCF
-1855170
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
43
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
0
Quarters > 1 > income Statement > cost Of Revenue
-
Quarters > 1 > income Statement > gross Profit
-
Quarters > 1 > income Statement > operating Expenses
1851160
Quarters > 1 > income Statement > operating Income
-1851160
Quarters > 1 > income Statement > interest Expense
6161
Quarters > 1 > income Statement > pretax Income
-1855153
Quarters > 1 > income Statement > net Income
-1855153
Quarters > 1 > income Statement > eps
-0.6447487546601411
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
2877327
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-1848992
Quarters > 1 > income Statement > operating Margin
-
Quarters > 1 > income Statement > total Other Income Expense Net
-3993
Quarters > 1 > income Statement > currency_symbol
USD
Quarters > 1 > balance Sheet > cash
2241980
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
-
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
2530166
Quarters > 1 > balance Sheet > property Plant Equipment
-
Quarters > 1 > balance Sheet > total Assets
2530166
Quarters > 1 > balance Sheet > payables
770610
Quarters > 1 > balance Sheet > short Term Debt
249716
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
2162807
Quarters > 1 > balance Sheet > equity
367359
Quarters > 1 > balance Sheet > currency_symbol
USD
Quarters > 1 > cash Flow > net Income
-1855153
Quarters > 1 > cash Flow > depreciation
-
Quarters > 1 > cash Flow > change In Working Capital
144987
Quarters > 1 > cash Flow > cash From Operations
-1142530
Quarters > 1 > cash Flow > capital Expenditures
0
Quarters > 1 > cash Flow > cash From Investing
-
Quarters > 1 > cash Flow > cash From Financing
2308582
Quarters > 1 > cash Flow > net Change In Cash
1166052
Quarters > 1 > cash Flow > currency_symbol
USD
Quarters > 1 > ratios > PE
-0.6447487546601411
Quarters > 1 > ratios > PB
22.870801695344333
Quarters > 1 > ratios > ROE
-504.9972914778187
Quarters > 1 > ratios > ROA
-73.3213947227178
Quarters > 1 > ratios > FCF
-1142530
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-
Quarters > 1 > health Score
17
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
0
Quarters > 2 > income Statement > cost Of Revenue
-
Quarters > 2 > income Statement > gross Profit
-
Quarters > 2 > income Statement > operating Expenses
2546669
Quarters > 2 > income Statement > operating Income
-2546669
Quarters > 2 > income Statement > interest Expense
8471
Quarters > 2 > income Statement > pretax Income
-2541704
Quarters > 2 > income Statement > net Income
-2541704
Quarters > 2 > income Statement > eps
-0.9879461969164871
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
2572715
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-2533233
Quarters > 2 > income Statement > operating Margin
-
Quarters > 2 > income Statement > total Other Income Expense Net
4965
Quarters > 2 > income Statement > currency_symbol
USD
Quarters > 2 > balance Sheet > cash
1075928
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
-
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
1661294
Quarters > 2 > balance Sheet > property Plant Equipment
-
Quarters > 2 > balance Sheet > total Assets
1661294
Quarters > 2 > balance Sheet > payables
838184
Quarters > 2 > balance Sheet > short Term Debt
271454
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
2475965
Quarters > 2 > balance Sheet > equity
-814671
Quarters > 2 > balance Sheet > currency_symbol
USD
Quarters > 2 > cash Flow > net Income
-2541704
Quarters > 2 > cash Flow > depreciation
-
Quarters > 2 > cash Flow > change In Working Capital
-366476
Quarters > 2 > cash Flow > cash From Operations
-2689000
Quarters > 2 > cash Flow > capital Expenditures
1
Quarters > 2 > cash Flow > cash From Investing
-
Quarters > 2 > cash Flow > cash From Financing
205568
Quarters > 2 > cash Flow > net Change In Cash
-2483433
Quarters > 2 > cash Flow > currency_symbol
USD
Quarters > 2 > ratios > PE
-0.9879461969164871
Quarters > 2 > ratios > PB
-9.221302587179364
Quarters > 2 > ratios > ROE
311.9914664938362
Quarters > 2 > ratios > ROA
-152.99543608777256
Quarters > 2 > ratios > FCF
-2689001
Quarters > 2 > ratios > Piotroski FScore
0
Quarters > 2 > ratios > fcf Percent
-
Quarters > 2 > health Score
38
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
0
Quarters > 3 > income Statement > cost Of Revenue
-
Quarters > 3 > income Statement > gross Profit
-
Quarters > 3 > income Statement > operating Expenses
3847464
Quarters > 3 > income Statement > operating Income
-3847464
Quarters > 3 > income Statement > interest Expense
758
Quarters > 3 > income Statement > pretax Income
-3820550
Quarters > 3 > income Statement > net Income
-3820550
Quarters > 3 > income Statement > eps
-1.9356778685073563
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
1973753
Quarters > 3 > income Statement > income Tax Expense
43276
Quarters > 3 > income Statement > EBITDA
-3819792
Quarters > 3 > income Statement > operating Margin
-
Quarters > 3 > income Statement > total Other Income Expense Net
26914
Quarters > 3 > income Statement > currency_symbol
USD
Quarters > 3 > balance Sheet > cash
3559361
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
-
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
3721624
Quarters > 3 > balance Sheet > property Plant Equipment
-
Quarters > 3 > balance Sheet > total Assets
3721624
Quarters > 3 > balance Sheet > payables
1089666
Quarters > 3 > balance Sheet > short Term Debt
-
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
2413982
Quarters > 3 > balance Sheet > equity
1307642
Quarters > 3 > balance Sheet > currency_symbol
USD
Quarters > 3 > cash Flow > net Income
-3820550
Quarters > 3 > cash Flow > depreciation
27672
Quarters > 3 > cash Flow > change In Working Capital
575799
Quarters > 3 > cash Flow > cash From Operations
-3033647
Quarters > 3 > cash Flow > capital Expenditures
0
Quarters > 3 > cash Flow > cash From Investing
-
Quarters > 3 > cash Flow > cash From Financing
1818771
Quarters > 3 > cash Flow > net Change In Cash
-1214876
Quarters > 3 > cash Flow > currency_symbol
USD
Quarters > 3 > ratios > PE
-1.9356778685073563
Quarters > 3 > ratios > PB
4.4074439028419095
Quarters > 3 > ratios > ROE
-292.1709458705058
Quarters > 3 > ratios > ROA
-102.65814063967773
Quarters > 3 > ratios > FCF
-3033647
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-
Quarters > 3 > health Score
28
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
0
Annuals > 0 > income Statement > cost Of Revenue
-
Annuals > 0 > income Statement > gross Profit
-
Annuals > 0 > income Statement > operating Expenses
12433792
Annuals > 0 > income Statement > operating Income
-12433792
Annuals > 0 > income Statement > interest Expense
13684
Annuals > 0 > income Statement > pretax Income
-12197568
Annuals > 0 > income Statement > net Income
-12197568
Annuals > 0 > income Statement > eps
-9.409598160905354
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
1296290
Annuals > 0 > income Statement > income Tax Expense
-12197568
Annuals > 0 > income Statement > EBITDA
-12433792
Annuals > 0 > income Statement > operating Margin
-
Annuals > 0 > income Statement > total Other Income Expense Net
236224
Annuals > 0 > income Statement > currency_symbol
USD
Annuals > 0 > balance Sheet > cash
3559361
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
-
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
3721624
Annuals > 0 > balance Sheet > property Plant Equipment
-
Annuals > 0 > balance Sheet > total Assets
3721624
Annuals > 0 > balance Sheet > payables
1089666
Annuals > 0 > balance Sheet > short Term Debt
-
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
2413982
Annuals > 0 > balance Sheet > equity
1307642
Annuals > 0 > balance Sheet > currency_symbol
USD
Annuals > 0 > cash Flow > net Income
-12197568
Annuals > 0 > cash Flow > depreciation
-222540
Annuals > 0 > cash Flow > change In Working Capital
564714
Annuals > 0 > cash Flow > cash From Operations
-10901991
Annuals > 0 > cash Flow > capital Expenditures
0
Annuals > 0 > cash Flow > cash From Investing
-
Annuals > 0 > cash Flow > cash From Financing
3526000
Annuals > 0 > cash Flow > net Change In Cash
-7375991
Annuals > 0 > cash Flow > currency_symbol
USD
Annuals > 0 > ratios > PE
-9.409598160905354
Annuals > 0 > ratios > PB
3.063174859785782
Annuals > 0 > ratios > ROE
-932.7910850217414
Annuals > 0 > ratios > ROA
-327.74853128634163
Annuals > 0 > ratios > FCF
-10901991
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-
Annuals > 0 > health Score
19
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
0
Annuals > 1 > income Statement > cost Of Revenue
-
Annuals > 1 > income Statement > gross Profit
-
Annuals > 1 > income Statement > operating Expenses
9455220
Annuals > 1 > income Statement > operating Income
-9455220
Annuals > 1 > income Statement > interest Expense
16505
Annuals > 1 > income Statement > pretax Income
-9319094
Annuals > 1 > income Statement > net Income
-9319094
Annuals > 1 > income Statement > eps
-107.08032954532398
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
87029
Annuals > 1 > income Statement > income Tax Expense
-15264
Annuals > 1 > income Statement > EBITDA
-9149958
Annuals > 1 > income Statement > operating Margin
-
Annuals > 1 > income Statement > total Other Income Expense Net
136126
Annuals > 1 > income Statement > currency_symbol
USD
Annuals > 1 > balance Sheet > cash
10935352
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
-
Annuals > 1 > balance Sheet > inventories
-
Annuals > 1 > balance Sheet > total Current Assets
10946393
Annuals > 1 > balance Sheet > property Plant Equipment
-
Annuals > 1 > balance Sheet > total Assets
10946393
Annuals > 1 > balance Sheet > payables
908577
Annuals > 1 > balance Sheet > short Term Debt
-
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
1815046
Annuals > 1 > balance Sheet > equity
9131347
Annuals > 1 > balance Sheet > currency_symbol
USD
Annuals > 1 > cash Flow > net Income
-9319094
Annuals > 1 > cash Flow > depreciation
152631
Annuals > 1 > cash Flow > change In Working Capital
837126
Annuals > 1 > cash Flow > cash From Operations
-7300106
Annuals > 1 > cash Flow > capital Expenditures
4
Annuals > 1 > cash Flow > cash From Investing
-
Annuals > 1 > cash Flow > cash From Financing
11724924
Annuals > 1 > cash Flow > net Change In Cash
4424818
Annuals > 1 > cash Flow > currency_symbol
USD
Annuals > 1 > ratios > PE
-107.08032954532398
Annuals > 1 > ratios > PB
0.029450157791616065
Annuals > 1 > ratios > ROE
-102.05607124556761
Annuals > 1 > ratios > ROA
-85.1339249376484
Annuals > 1 > ratios > FCF
-7300110
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-
Annuals > 1 > health Score
33
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
0
Annuals > 2 > income Statement > cost Of Revenue
-
Annuals > 2 > income Statement > gross Profit
-
Annuals > 2 > income Statement > operating Expenses
6881938
Annuals > 2 > income Statement > operating Income
-6881938
Annuals > 2 > income Statement > interest Expense
1591244
Annuals > 2 > income Statement > pretax Income
-8473182
Annuals > 2 > income Statement > net Income
-8473182
Annuals > 2 > income Statement > eps
-280.7734773676188
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
30178
Annuals > 2 > income Statement > income Tax Expense
-228485
Annuals > 2 > income Statement > EBITDA
-6653453
Annuals > 2 > income Statement > operating Margin
-
Annuals > 2 > income Statement > total Other Income Expense Net
-1591244
Annuals > 2 > income Statement > currency_symbol
USD
Annuals > 2 > balance Sheet > cash
6510534
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
-
Annuals > 2 > balance Sheet > inventories
-
Annuals > 2 > balance Sheet > total Current Assets
6688628
Annuals > 2 > balance Sheet > property Plant Equipment
-
Annuals > 2 > balance Sheet > total Assets
6688628
Annuals > 2 > balance Sheet > payables
954505
Annuals > 2 > balance Sheet > short Term Debt
-
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
1144973
Annuals > 2 > balance Sheet > equity
5543655
Annuals > 2 > balance Sheet > currency_symbol
USD
Annuals > 2 > cash Flow > net Income
-8473182
Annuals > 2 > cash Flow > depreciation
228485
Annuals > 2 > cash Flow > change In Working Capital
-569112
Annuals > 2 > cash Flow > cash From Operations
-6557950
Annuals > 2 > cash Flow > capital Expenditures
0
Annuals > 2 > cash Flow > cash From Investing
-
Annuals > 2 > cash Flow > cash From Financing
13064128
Annuals > 2 > cash Flow > net Change In Cash
6506178
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
-280.7734773676188
Annuals > 2 > ratios > PB
0.016821035941089406
Annuals > 2 > ratios > ROE
-152.84468459887927
Annuals > 2 > ratios > ROA
-126.68041936253593
Annuals > 2 > ratios > FCF
-6557950
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-
Annuals > 2 > health Score
33
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
0
Annuals > 3 > income Statement > cost Of Revenue
-
Annuals > 3 > income Statement > gross Profit
-
Annuals > 3 > income Statement > operating Expenses
3208017
Annuals > 3 > income Statement > operating Income
-3208017
Annuals > 3 > income Statement > interest Expense
831277
Annuals > 3 > income Statement > pretax Income
-2206643
Annuals > 3 > income Statement > net Income
-2206643
Annuals > 3 > income Statement > eps
-72.8144860584062
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
30305
Annuals > 3 > income Statement > income Tax Expense
831277
Annuals > 3 > income Statement > EBITDA
-1375367
Annuals > 3 > income Statement > operating Margin
-
Annuals > 3 > income Statement > total Other Income Expense Net
1001374
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
4356
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
-
Annuals > 3 > balance Sheet > inventories
-
Annuals > 3 > balance Sheet > total Current Assets
621677
Annuals > 3 > balance Sheet > property Plant Equipment
-
Annuals > 3 > balance Sheet > total Assets
621677
Annuals > 3 > balance Sheet > payables
1463059
Annuals > 3 > balance Sheet > short Term Debt
1392544
Annuals > 3 > balance Sheet > long Term Debt
772899
Annuals > 3 > balance Sheet > total Liabilities
5306579
Annuals > 3 > balance Sheet > equity
-4684902
Annuals > 3 > balance Sheet > currency_symbol
USD
Annuals > 3 > cash Flow > net Income
-2206643
Annuals > 3 > cash Flow > depreciation
236558
Annuals > 3 > cash Flow > change In Working Capital
1047215
Annuals > 3 > cash Flow > cash From Operations
-1086244
Annuals > 3 > cash Flow > capital Expenditures
0
Annuals > 3 > cash Flow > cash From Investing
-
Annuals > 3 > cash Flow > cash From Financing
898748
Annuals > 3 > cash Flow > net Change In Cash
-187496
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
-72.8144860584062
Annuals > 3 > ratios > PB
-0.01998813422351204
Annuals > 3 > ratios > ROE
47.101156011374414
Annuals > 3 > ratios > ROA
-354.95007857778234
Annuals > 3 > ratios > FCF
-1086244
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-
Annuals > 3 > health Score
30
Valuation > metrics > PE
-0.336729997185156
Valuation > metrics > PB
2.9613138240928625
Valuation > final Score
80
Valuation > verdict
Fair
Profitability > metrics > ROE
-34.149424508601136
Profitability > metrics > ROA
-27.298802578597908
Profitability > final Score
15
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.25094953928030794
Risk > metrics > Interest Coverage
-216.99606135986733
Risk > final Score
-808
Risk > verdict
High
Liquidity > metrics > Current Ratio
11.678924966704791
Liquidity > metrics > Quick Ratio
11.678924966704791
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
20
Prev Valuations > 1
50
Prev Valuations > 2
35.92556097158091
Prev Profitabilities > 0
15
Prev Profitabilities > 1
55
Prev Profitabilities > 2
15
Prev Risks > 0
-1196
Prev Risks > 1
-1173
Prev Risks > 2
-20273
Prev Liquidities > 0
100
Prev Liquidities > 1
87
Prev Liquidities > 2
100
Updated At
2026-01-20T22:41:27.148Z
Earnings History > 0 > period
2025-09-30
Earnings History > 0 > report Date
2025-11-12
Earnings History > 0 > date
2025-09-30
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-0.34
Earnings History > 0 > eps Estimate
-
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2025-06-30
Earnings History > 1 > report Date
2025-08-14
Earnings History > 1 > date
2025-06-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-0.64
Earnings History > 1 > eps Estimate
0
Earnings History > 1 > eps Difference
-0.64
Earnings History > 1 > surprise Percent
-
Earnings History > 2 > period
2025-03-31
Earnings History > 2 > report Date
2025-05-12
Earnings History > 2 > date
2025-03-31
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
-0.99
Earnings History > 2 > eps Estimate
-
Earnings History > 2 > eps Difference
0
Earnings History > 2 > surprise Percent
-
Earnings History > 3 > period
2024-12-31
Earnings History > 3 > report Date
2025-03-26
Earnings History > 3 > date
2024-12-31
Earnings History > 3 > before After Market
-
Earnings History > 3 > currency
-
Earnings History > 3 > eps Actual
-2.14
Earnings History > 3 > eps Estimate
-
Earnings History > 3 > eps Difference
0
Earnings History > 3 > surprise Percent
-
Earnings History > 4 > period
2024-09-30
Earnings History > 4 > report Date
2024-11-27
Earnings History > 4 > date
2024-09-30
Earnings History > 4 > before After Market
-
Earnings History > 4 > currency
USD
Earnings History > 4 > eps Actual
-2.4532
Earnings History > 4 > eps Estimate
-
Earnings History > 4 > eps Difference
0
Earnings History > 4 > surprise Percent
-
Earnings History > 5 > period
2024-06-30
Earnings History > 5 > report Date
2024-08-28
Earnings History > 5 > date
2024-06-30
Earnings History > 5 > before After Market
-
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
-2.4165
Earnings History > 5 > eps Estimate
-
Earnings History > 5 > eps Difference
0
Earnings History > 5 > surprise Percent
-
Earnings History > 6 > period
2024-03-31
Earnings History > 6 > report Date
2024-05-09
Earnings History > 6 > date
2024-03-31
Earnings History > 6 > before After Market
BeforeMarket
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
-2.8782
Earnings History > 6 > eps Estimate
-
Earnings History > 6 > eps Difference
0
Earnings History > 6 > surprise Percent
-
Earnings History > 7 > period
2023-12-31
Earnings History > 7 > report Date
2024-02-23
Earnings History > 7 > date
2023-12-31
Earnings History > 7 > before After Market
BeforeMarket
Earnings History > 7 > currency
USD
Earnings History > 7 > eps Actual
-0.71
Earnings History > 7 > eps Estimate
-1.25
Earnings History > 7 > eps Difference
0.54
Earnings History > 7 > surprise Percent
43.2
Earnings History > 8 > period
2023-09-30
Earnings History > 8 > report Date
2023-11-07
Earnings History > 8 > date
2023-09-30
Earnings History > 8 > before After Market
AfterMarket
Earnings History > 8 > currency
USD
Earnings History > 8 > eps Actual
-0.11
Earnings History > 8 > eps Estimate
-0.06
Earnings History > 8 > eps Difference
-0.05
Earnings History > 8 > surprise Percent
-83.3333
Earnings History > 9 > period
2023-06-30
Earnings History > 9 > report Date
2023-08-30
Earnings History > 9 > date
2023-06-30
Earnings History > 9 > before After Market
-
Earnings History > 9 > currency
USD
Earnings History > 9 > eps Actual
-4
Earnings History > 9 > eps Estimate
-0.16
Earnings History > 9 > eps Difference
-3.84
Earnings History > 9 > surprise Percent
-2400
Earnings History > 10 > period
2023-03-31
Earnings History > 10 > report Date
2023-05-31
Earnings History > 10 > date
2023-03-31
Earnings History > 10 > before After Market
-
Earnings History > 10 > currency
USD
Earnings History > 10 > eps Actual
-5.75
Earnings History > 10 > eps Estimate
-0.23
Earnings History > 10 > eps Difference
-5.52
Earnings History > 10 > surprise Percent
-2400
Earnings History > 11 > period
2022-12-31
Earnings History > 11 > report Date
2023-03-16
Earnings History > 11 > date
2022-12-31
Earnings History > 11 > before After Market
-
Earnings History > 11 > currency
USD
Earnings History > 11 > eps Actual
-0.15
Earnings History > 11 > eps Estimate
-
Earnings History > 11 > eps Difference
0
Earnings History > 11 > surprise Percent
-
Earnings History > 12 > period
2022-09-30
Earnings History > 12 > report Date
2022-11-14
Earnings History > 12 > date
2022-09-30
Earnings History > 12 > before After Market
-
Earnings History > 12 > currency
USD
Earnings History > 12 > eps Actual
-0.18
Earnings History > 12 > eps Estimate
-
Earnings History > 12 > eps Difference
0
Earnings History > 12 > surprise Percent
-
Earnings History > 13 > period
2022-06-30
Earnings History > 13 > report Date
2022-08-11
Earnings History > 13 > date
2022-06-30
Earnings History > 13 > before After Market
-
Earnings History > 13 > currency
USD
Earnings History > 13 > eps Actual
-0.14
Earnings History > 13 > eps Estimate
-
Earnings History > 13 > eps Difference
0
Earnings History > 13 > surprise Percent
-
Earnings History > 14 > period
2022-03-31
Earnings History > 14 > report Date
2022-04-01
Earnings History > 14 > date
2022-03-31
Earnings History > 14 > before After Market
-
Earnings History > 14 > currency
USD
Earnings History > 14 > eps Actual
0.22
Earnings History > 14 > eps Estimate
-
Earnings History > 14 > eps Difference
0
Earnings History > 14 > surprise Percent
-
Earnings History > 15 > period
2021-12-31
Earnings History > 15 > report Date
2022-01-13
Earnings History > 15 > date
2021-12-31
Earnings History > 15 > before After Market
-
Earnings History > 15 > currency
USD
Earnings History > 15 > eps Actual
-0.08
Earnings History > 15 > eps Estimate
0
Earnings History > 15 > eps Difference
-0.08
Earnings History > 15 > surprise Percent
-
Earnings History > 16 > period
2021-06-30
Earnings History > 16 > report Date
2021-09-27
Earnings History > 16 > date
2021-06-30
Earnings History > 16 > before After Market
-
Earnings History > 16 > currency
USD
Earnings History > 16 > eps Actual
-0.24
Earnings History > 16 > eps Estimate
0
Earnings History > 16 > eps Difference
-0.24
Earnings History > 16 > surprise Percent
-
Tharimmune, Inc., a clinical-stage biotechnology company, engages in the development of therapeutic candidates for immunology and inflammation conditions in the United States. It is involved in the development of TH104 for the proposed indication of temporary prophylaxis of respiratory and/or nervous system depression in military personnel and chemical incident responders entering and area contaminated with opioids, as well as is in phase 2 study in patients with chronic pruritus in primary biliary cholangitis. The company also engages in the development of TH023 to treat autoimmune indications; and HS1940, a bispecific biologic against PD-1 and vascular endothelial growth receptor antibody that targets both receptors. It has a research collaboration and product license agreement with Minotaur Therapeutics, Inc. for the development of proprietary targeted biologics. The company was formerly known as Hillstream BioPharma, Inc. and changed its name to Tharimmune, Inc. in September 2023. Tharimmune, Inc. was incorporated in 2017 and is based in Red Bank, New Jersey.
Stock Price
$0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/ATharimmune Announces $55 Million Underwritten Registered Offering TipRanks
Read more →Tharimmune, Inc. Announces Pricing of $55 Million Underwritten Registered Offering marketscreener.com
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Rating:
STRONG BUY
Target Price:
$5
Analyst Picks
Strong Buy
1
Buy
0
Hold
0
Sell
0
Strong Sell
0
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very High
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Debt to Equity
-
Very High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of Tharimmune Inc.
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2025-09-30
EPS Actual
-0.34
EPS Estimate
—
EPS Difference
0
Surprise Percent
0%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.